Form 8-K - Current report:
SEC Accession No. 0001193125-25-076885
Filing Date
2025-04-09
Accepted
2025-04-09 16:37:08
Documents
13
Period of Report
2025-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d937351d8k.htm   iXBRL 8-K 25767
  Complete submission text file 0001193125-25-076885.txt   143972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gh-20250403.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20250403_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20250403_pre.xml EX-101.PRE 10817
15 EXTRACTED XBRL INSTANCE DOCUMENT d937351d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 25825618
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)